Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Curative Gene Therapy Coverage May Need Government-Funded Risk Pools
Sep 16 2019
•
By
Cathy Kelly
Disparity in access between Medicaid and private plans for high-cost therapies could be particularly problematic, Gottlieb says. • Source: Shutterstock
More from Pricing Debate
More from Market Access